New method could help estimate wildlife disease spread

A new method could be used by biologists to estimate the prevalence of disease in free-ranging wildlife and help determine how many samples are needed to detect a disease.

Aggressive colon tumor may be vulnerable to cholesterol therapy

A preclinical study has shown that colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend on the ramped-up production of cholesterol, which points to the possibility of using cholesterol-lowering drugs to prevent or treat such tumors.

Discontinuing anti-obesity drug tirzepatide leads to weight regain

A clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found remaining on the anti-obesity drug tirzepatide promoted additional weight loss and preserved improvements in metabolic and cardiovascular health.

Team designing digital health tools for pregnant refugees wins NAM prize

An intercampus collaboration that aims to provide digital health care tools to pregnant refugee women, who are at elevated risk for pregnancy complications but often afraid to seek medical care, has been awarded a National Academy of Medicine Catalyst Prize.

Specific genetic variant may help prevent obesity

A preclinical study by Weill Cornell Medicine investigators shows that a specific human genetic variant of a receptor that stimulates insulin release may help individuals be more resistant to obesity. 

Race doesn’t impact cardiovascular risk calculations

Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Nonalcoholic beer at higher risk for foodborne pathogens

The lack of alcohol in nonalcoholic or low-alcohol beer – particularly during manufacturing, storage and pouring – may prompt conditions ripe for foodborne pathogen growth.

Immune protein may induce dementia unrelated to high blood pressure

Researchers at Weill Cornell Medicine have found that controlling high blood pressure may not be enough to prevent associated cognitive declines. The findings suggest new approaches to prevent damage to brain cells.

Deep brain stimulation improves cognition after injury

Five people who had life-altering, seemingly irreversible cognitive deficits following moderate to severe traumatic brain injuries showed substantial improvements in their cognition and quality of life after receiving an experimental form of deep brain stimulation in a phase 1 clinical trial.